Onvatilimab Antibody
Onvatilimab (JNJ-61610588) is a human IgG1κ monoclonal antibody targeting VISTA, an immune checkpoint protein. It exhibits antitumor activity and is investigated for treating advanced head and neck cancers in preclinical and clinical research settings, focusing on modulating T-cell function.
Product Specifications
Product Name Alternative
JNJ-61610588, JNJ61610588, JNJ 61610588, Onvatilimab, V-domain Ig suppressor of T-cell activation (VISTA)
Target
PD-1/PD-L1, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
4.22 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.52 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx238356 100 µg
STT3B, Catalytic Subunit of The Oligosaccharyltransferase Complex (STT3B) Antibody
Sign In for Pricing
View Details 
E45H19863-2 20 µg
Angiopoietin 2 (ANGPT2) (NM_001147) Human Over-expression Lysate
Sign In for Pricing
View Details MBS1337347-01 0.02 mg (E-Coli)
Recombinant Bacteroides fragilis Spermidine/putrescine import ATP-binding protein PotA (potA)
Sign In for Pricing
View Details